Calliditas

CALT

CALT Calliditas NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CALT Chart
    See on advanced chart >

    About

    Calliditas Therapeutics AB was formed in February 20, 2004. The company is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic...
    • Highlight
      A commercial stage biopharma company based in Stockholm, Sweden focused on identifying, developing and commercializing novel treatments in orphan indications
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/05/2020
    • Established Date
      02/20/2004
    • Full-time Employees
      178
    • Address
      Kungsbron 1 D5 SE-111 22 Stockholm Sweden
    • Tel
      46-8-4113005
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-03-02 17:37:39